Annales Pharmaceutiques Francaises, том 79, издание 5, номера страниц: 500-510
Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study
Тип документа: Journal Article
Дата публикации: 2021-09-25
Издатель: Elsevier
Название журнала: Annales Pharmaceutiques Francaises
Квартиль по SCImago: Q3
Квартиль по Web of Science: —
Импакт-фактор 2021: —
ISSN: 00034509
Pharmacology
Pharmaceutical Science
Пристатейные ссылки: 18
Цитируется в публикациях: 1
Development and validation of RP-HPLC method for simultaneous estimation of docetaxel and ritonavir in PLGA nanoparticles.
Kumbhar P.S., Diwate S.K., Mali U.G., Shinde T.U., Disouza J.I., Manjappa A.S.
Q3
Annales Pharmaceutiques Francaises,
2020,
цитирований: 5
Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells
Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.
Q2
Journal of Biomedical Materials Research - Part B Applied Biomaterials,
2018,
цитирований: 28
Current development in the formulations of non‐injection administration of paclitaxel
Du X., Khan A.R., Fu M., Ji J., Yu A., Zhai G.
Q1
International Journal of Pharmaceutics,
2018,
цитирований: 27
,
Open Access
Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency
Zhang Z., Wang X., Li B., Hou Y., Cai Z., Yang J., Li Y.
Q1
RSC Advances,
2018,
цитирований: 34
,
Open Access
Alpha-fetoprotein: A fabulous biomarker in hepatocellular, gastric and rectal cancer diagnosis
Naz Z., Usman S., Saleem K., Ahmed S., Bashir H., Bilal M., Sumrin A.
Q3
Biomedical Research,
2018,
цитирований: 12
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF PACLITAXEL IN PHARMACEUTICAL DOSAGE FORMS
Suman P.
World Journal of Pharmacy and Pharmaceutical Sciences,
2017,
цитирований: 1
The docetaxel polymeric form and its antitumor activity
Nikolskaya E.D., Zhunina O.A., Yabbarov N.G., Tereshchenko O.G., Godovannyy A.V., Gukasova N.V., Severin E.S.
Q4
Russian Journal of Bioorganic Chemistry,
2017,
цитирований: 4
Development and validation of a reversed‐phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers
Furman C., Carpentier R., Barczyk A., Chavatte P., Betbeder D., Lipka E.
Q2
Electrophoresis,
2017,
цитирований: 7
Development and Validation of a Rapid RP-HPLC-DAD Analysis Method for the Simultaneous Quantitation of Paclitaxel and Lapatinib in a Polymeric Micelle Formulation
Saadat E.
Q2
Scientia Pharmaceutica,
2016,
цитирований: 7
,
Open Access
Сравнительные исследования противоопухолевой активности и безопасности нового препарата белково-векторной доставки актиномицинового ряда на экспериментальных опухолевых моделях у мышей
Kruglyi B.I., Nikolskaya E.D., Severin E.S., Barsegyan G.G., Yabbarov N.G., Tereshchenko O.G., Zhunina O.A., Zenin V.A., Tyulyaev A.I.
Q4
Onkopediatria,
2016,
цитирований: 4
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Kampan N.C., Madondo M.T., McNally O.M., Quinn M., Plebanski M.
Q2
BioMed Research International,
2015,
цитирований: 141
,
Open Access
How Taxol/paclitaxel kills cancer cells
Weaver B.A.
Q1
Molecular Biology of the Cell,
2014,
цитирований: 726
Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel.
Choudhury H., Gorain B., Karmakar S., Pal T.K.
Q3
Journal of Chromatographic Science,
2013,
цитирований: 26
Isolation and characterization of the recombinant human α-fetoprotein fragment corresponding to the C-terminal structural domain
Sharapova O.A., Pozdnyakova N.V., Laurinavichyute D.K., Yurkova M.S., Posypanova G.A., Andronova S.M., Fedorov A.N., Severin S.E., Severin E.S.
Q4
Russian Journal of Bioorganic Chemistry,
2010,
цитирований: 3
PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches.
Hung L., Teh S., Jester J., Lee A.P.
Q1
Lab on a Chip,
2010,
цитирований: 124
Метрики
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Копировать
1. Sokol M. и др. Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study // Annales Pharmaceutiques Françaises. 2021. Т. 79. № 5. С. 500–510.
Цитировать
RIS
Копировать
TY - JOUR
DO - 10.1016/j.pharma.2021.02.001
UR - http://dx.doi.org/10.1016/j.pharma.2021.02.001
TI - Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study
T2 - Annales Pharmaceutiques Françaises
AU - Sokol, M.
AU - Zenin, V.
AU - Yabbarov, N.
AU - Mollaev, M.
AU - Zabolotsky, A.
AU - Mollaeva, M.
AU - Fomicheva, M.
AU - Kuznetsov, S.
AU - Popenko, V.
AU - Seregina, I.
AU - Nikolskaya, E.
PY - 2021
DA - 2021/09
PB - Elsevier BV
SP - 500-510
IS - 5
VL - 79
SN - 0003-4509
ER -
Цитировать
BibTex
Копировать
@article{Sokol_2021,
doi = {10.1016/j.pharma.2021.02.001},
url = {https://doi.org/10.1016%2Fj.pharma.2021.02.001},
year = 2021,
month = {sep},
publisher = {Elsevier {BV}},
volume = {79},
number = {5},
pages = {500--510},
author = {M. Sokol and V. Zenin and N. Yabbarov and M. Mollaev and A. Zabolotsky and M. Mollaeva and M. Fomicheva and S. Kuznetsov and V. Popenko and I. Seregina and E. Nikolskaya},
title = {Validated {HPLC} method for paclitaxel determination in {PLGA} submicron particles conjugated with $\upalpha$-fetoprotein third domain: Sample preparation case study},
journal = {Annales Pharmaceutiques Fran{\c{c}}aises}
}
Цитировать
MLA
Копировать
Sokol, M., et al. “Validated HPLC Method for Paclitaxel Determination in PLGA Submicron Particles Conjugated with α-Fetoprotein Third Domain: Sample Preparation Case Study.” Annales Pharmaceutiques Françaises, vol. 79, no. 5, Sept. 2021, pp. 500–10. Crossref, https://doi.org/10.1016/j.pharma.2021.02.001.